IRIS
LATRONICO, TIZIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.723
AS - Asia 1.681
EU - Europa 1.515
SA - Sud America 423
Continente sconosciuto - Info sul continente non disponibili 187
AF - Africa 109
OC - Oceania 7
Totale 7.645
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.637
SG - Singapore 655
IT - Italia 581
CN - Cina 419
BR - Brasile 337
HK - Hong Kong 212
SE - Svezia 195
RU - Federazione Russa 137
DE - Germania 136
FR - Francia 111
VN - Vietnam 107
FI - Finlandia 87
UA - Ucraina 71
GB - Regno Unito 70
BD - Bangladesh 65
CI - Costa d'Avorio 55
IN - India 55
CA - Canada 48
AR - Argentina 27
IQ - Iraq 20
NL - Olanda 20
BE - Belgio 19
PK - Pakistan 19
PL - Polonia 19
TR - Turchia 19
ID - Indonesia 16
ZA - Sudafrica 16
CO - Colombia 15
MX - Messico 15
VE - Venezuela 15
JP - Giappone 14
AT - Austria 12
EC - Ecuador 11
ES - Italia 11
PH - Filippine 11
IE - Irlanda 10
MA - Marocco 10
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
LT - Lituania 8
AU - Australia 7
JO - Giordania 7
UZ - Uzbekistan 7
CL - Cile 6
DZ - Algeria 6
ET - Etiopia 6
TN - Tunisia 6
CR - Costa Rica 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
MY - Malesia 4
PS - Palestinian Territory 4
BO - Bolivia 3
CH - Svizzera 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
IR - Iran 3
JM - Giamaica 3
KZ - Kazakistan 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KE - Kenya 2
KR - Corea 2
LB - Libano 2
MD - Moldavia 2
MN - Mongolia 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BM - Bermuda 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MW - Malawi 1
PR - Porto Rico 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 7.458
Salva come PNG Salva come JPEG
Città #
Ashburn 396
San Jose 345
Singapore 320
Woodbridge 264
Chandler 258
Fairfield 214
Hong Kong 207
Houston 169
Milan 160
Nyköping 160
Jacksonville 146
Ann Arbor 143
Beijing 130
Council Bluffs 101
Wilmington 100
Seattle 90
Cambridge 85
Bari 83
New York 75
Rome 65
Abidjan 55
Lauterbourg 54
Lawrence 49
Roxbury 47
Boardman 46
Los Angeles 45
Brooklyn 41
Dallas 40
Ho Chi Minh City 39
Columbus 37
Nanjing 37
Marseille 35
Santa Clara 33
São Paulo 30
Des Moines 26
Helsinki 26
Munich 26
Chicago 22
Falkenstein 22
Turku 21
Hanoi 20
Brussels 17
Jiaxing 16
Rio de Janeiro 16
Buffalo 15
Moscow 15
Spongano 15
Denver 14
Warsaw 14
Guangzhou 13
Jakarta 13
Leverano 13
Montreal 13
Princeton 13
Toronto 13
Atlanta 12
Baghdad 12
Figino 12
Inglewood 12
Wuhan 12
Amsterdam 11
Changsha 11
Dublin 11
Falls Church 11
Grottaglie 11
London 11
Nuremberg 11
Orem 11
Palermo 11
San Diego 11
San Francisco 11
Turin 11
Paris 10
Shenyang 10
Vienna 10
Chennai 9
Frankfurt am Main 9
Phoenix 9
Porto Alegre 9
Shanghai 9
Tokyo 9
Da Nang 8
Hebei 8
Tianjin 8
Amman 7
Auburn Hills 7
Caracas 7
Nanchang 7
Salvador 7
Addis Ababa 6
Belo Horizonte 6
Boston 6
Johannesburg 6
Naples 6
Piscataway 6
Tashkent 6
Washington 6
Adelfia 5
Algiers 5
Brno 5
Totale 4.860
Salva come PNG Salva come JPEG
Nome #
Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures 262
FAD synthase deficiency: a severe mitochondrial myopathy involving a secondary reduction of RFVT2 expression 217
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 199
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 187
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 186
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 178
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 158
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 151
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 148
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 146
Retrograde response to mitochondrial dysfunctions associated to LOF variations in FLAD1 exon 2: unraveling the importance of RFVT2 141
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 141
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 140
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 140
High surface area mesoporous silica nanoparticles with tunable size in the sub-micrometer regime: Insights on the size and porosity control mechanisms 133
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 128
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 126
Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies 116
Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders 115
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 114
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 114
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 112
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 112
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 110
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 109
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 108
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 105
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 104
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 104
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 103
Oral administration of nucleotides in calves: Effects on oxidative status, immune response, and intestinal mucosa development 101
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 100
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 100
Bioassay-guided identification of bioactive protein compounds from the Mediterranean demosponge Tethya meloni 99
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 98
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 97
DEVELOPMENTAL OMEGA-3 SUPPLEMENTATION IMPROVES MOTOR SKILLS IN JUVENILE RATS 95
Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases 94
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 94
Matrix Metalloproteinases in CNS Inflammation. 93
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 91
Evaluation of Cell Toxicity and Matrix Metalloproteinase-9 Inhibition by combination of Antiretroviral Drugs in Cultured Primary Astrocytes. Implication for the treatment of neuroAIDS. 91
null 91
null 90
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 89
null 87
Differential Modulation of NF-κ B in Neurons and Astrocytes Underlies Neuroprotection and Antigliosis Activity of Natural Antioxidant Molecules 86
Resveratrol impinges on retrograde communication without inducing mitochondrial biogenesis in aged rat soleus muscle 83
COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality 83
Inhibition of myelin-cleaving proteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II. 82
Antioxidant Activity of Polysaccharides from the Edible Mushroom Pleurotus eryngii 78
Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19 75
Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients 71
The effects of dietary antioxidants on gelatinase activity in cultured rat astrocytes. implications for the complementary treatment of multiple sclerosis. 70
Unravelling the relevance of fad synthetase in human physiopathology. A biotechnological approach. 70
Use of a commercial feed supplement based on yeast products and microalgae with or without nucleotide addition in calves 68
Neuroprotective Effect of Resveratrol against Manganese-Induced Oxidative Stress and Matrix Metalloproteinase-9 in an “In Vivo” Model of Neurotoxicity 67
Interferon-alpha/beta treatment inhibits metalloproteinase activity in rat astrocyte cell cultures 66
Use of a commercial feed supplement based on diatom earth and yeast products on oxidative status and in vitro immune response in buffaloes during peripartum 65
Neuroprotective potential of isothiocyanates in an in vitro model of neuroinflammation 64
Lead exposure of rats during and after pregnancy induces anti-myelin proteolytic activity: a potential mechanism for lead-induced neurotoxicity 64
Impact of manganese neurotoxicity on MMP-9 production and superoxide dismutase activity in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 63
Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia 63
Interferon-Beta Treatment Inhibits Matrix metalloproteinases in rat glial cell cultures 63
Intra- and interspecific variation in electrophoretic profiles of Tethya spp.: an integration to morfological classification system 62
Increasing Oxygen Partial Pressures Induce a Distinct Transcriptional Response in Human PBMC: A Pilot Study on the "Normobaric Oxygen Paradox" 62
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects 62
Edible Mushrooms as Source of Fibrin(ogen)olytic Enzymes: Comparison between Four Cultivated Species 62
Inhibition of calpain activity and expression by interferon-beta in rat astrocytes: implications for MS pathogenesis and treatment. 56
Inhibitory effect of immunomodulatory and immunosuppressive therapies on the activity of gelatinases and urokinase-type plasminogen activator in peripheral blood mononuclear cells from patients with multiple sclerosis 50
null 47
Inhibition of MMP-2 and MMP-9 by Dietary Antioxidants in THP-1 Macrophages and Sera from Patients with Breast Cancer 43
Enhancing Antioxidants Performance of Ceria Nanoparticles in Biological Environment via Surface Engineering with o-Quinone Functionalities 38
Increased Antioxidant Performance of Lignin by Biodegradation Obtained from an Extract of the Mushroom Pleurotus eryngii 35
Molecular mechanisms of cell toxicity and Matrix Metalloproteinase-9 inhibition by Antiretroviral Drugs in Cultured Primary Astrocytes. 35
Metalloproteinases and their inhibitors as therapeutic targets for multiple sclerosis: current evidence and future perspectives 29
Reliable New Biomarkers of Mitochondrial Oxidative Stress and Neuroinflammation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients: A Pilot Study 28
null 18
null 15
Hydrolytic Enzymes in the Secretome of the Mushrooms P. eryngii and P. ostreatus: A Comparison Between the Two Species 5
Totale 7.645
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.167
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022312 0 0 2 5 19 24 12 20 49 29 54 98
2022/2023752 77 79 53 68 86 96 9 91 131 33 15 14
2023/2024281 17 49 13 60 23 63 4 2 5 11 6 28
2024/20251.254 111 29 72 34 44 72 158 95 54 70 167 348
2025/20262.980 377 160 173 263 308 146 257 77 439 291 151 338
2026/2027376 115 164 97 0 0 0 0 0 0 0 0 0
Totale 7.645